Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Marinus Pharma Raises US$21 Million In Series C Financing 11
Marinus Pharmaceuticals Raises USD11.43 in Venture Financing 13
Marinus Pharma Raises USD21.8 Million in Venture Financing 14
Licensing Agreements 15
Marinus Pharma Enters into Licensing Agreement with Ligand Pharma 15
CyDex Pharma Enters into Licensing Agreement with Marinus Pharma 16
Equity Offering 17
Marinus Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 17
Marinus Pharma Raises USD40.3 Million in Public Offering of Shares 18
Marinus Pharma Raises USD30 Million in Public Offering of Shares 20
Marinus Pharma Files Registration Statement for Public Offering of Shares for up to USD35 Million 21
Marinus Pharma Completes IPO 22
Marinus Pharmaceuticals Inc – Key Competitors 24
Marinus Pharmaceuticals Inc – Key Employees 25
Marinus Pharmaceuticals Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 02, 2018: Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results 27
May 02, 2018: Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results 29
Mar 06, 2018: Marinus Pharmaceuticals Provides Business Update and 2017 Financial Results 30
Oct 31, 2017: Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2017 Financial Results 32
Aug 01, 2017: Marinus Pharmaceuticals Reports Second Quarter 2017 Financial Results 34
Mar 13, 2017: Marinus Pharmaceuticals Provides Business Update and 2016 Financial Results 35
Corporate Communications 36
Apr 11, 2017: Dr. Lorianne K. Masuoka Joins Marinus Pharmaceuticals as Chief Medical Officer 36
Feb 01, 2017: Marinus Appoints Michael R. Dougherty to its Board of Directors 37
Product Approvals 38
Jun 29, 2017: FDA Grants Orphan Drug Designation for Ganaxolone in CDKL5 Disorder 38
Jan 03, 2017: Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone to Treat Fragile X Syndrome 39
Clinical Trials 40
Sep 11, 2017: Marinus Announces Successful Clinical Trial Results and Declares CDKL5 Disorder Its Lead Pediatric Orphan Epilepsy Program for Ganaxolone 40
Aug 01, 2017: Marinus Pharmaceuticals Announces Update on Ganaxolone 42
Jun 27, 2017: Marinus Pharmaceuticals Launches the Ganaxolone Clinical Program in Patients with Postpartum Depression 43
Apr 18, 2017: Marinus to present Ganaxolone DATA at American academy of neurology annual meeting 44
Apr 10, 2017: Ganaxolone IV Clinical Data Presented at Leading International Status Epilepticus Medical Conference 45
Feb 14, 2017: Ganaxolone Reduces Seizures and Improves Behaviors in Angelman Syndrome Preclinical Model 46
Jan 23, 2017: Marinus Announces Positive Preliminary Data From Children With CDKL5 Genetic Disorder 47
Jan 05, 2017: Marinus Provides Business Outlook for 2017 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Marinus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Marinus Pharma Raises US$21 Million In Series C Financing 11
Marinus Pharmaceuticals Raises USD11.43 in Venture Financing 13
Marinus Pharma Raises USD21.8 Million in Venture Financing 14
Marinus Pharma Enters into Licensing Agreement with Ligand Pharma 15
CyDex Pharma Enters into Licensing Agreement with Marinus Pharma 16
Marinus Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 17
Marinus Pharma Raises USD40.3 Million in Public Offering of Shares 18
Marinus Pharma Raises USD30 Million in Public Offering of Shares 20
Marinus Pharma Files Registration Statement for Public Offering of Shares for up to USD35 Million 21
Marinus Pharma Completes IPO 22
Marinus Pharmaceuticals Inc, Key Competitors 24
Marinus Pharmaceuticals Inc, Key Employees 25
List of Figures
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Marinus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9